Pretomanid
CAS 187235-37-6 2 FDA-DMF suppliersSmall Molecule
Overview
Pretomanid is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL227875).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Pretomanid expires — and exclusivity 13 Aug 2029. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- (6S)-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine
- Canonical SMILES
- C1[C@@H](COC2=NC(=CN21)[N+](=O)[O-])OCC3=CC=C(C=C3)OC(F)(F)F
- InChIKey
- ZLHZLMOSPGACSZ-NSHDSACASA-N
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.